Deutsche Bank Aktiengesellschaft »

Verve Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $369k 26k 13.94
2023-09-30 $367k 28k 13.26
2023-06-30 $476k 25k 18.75
2023-03-31 $549k 38k 14.42
2022-12-31 $500k 26k 19.35
2022-09-30 $700k 20k 34.28
2022-06-30 $0 18k 0.00
2022-03-31 $486k 21k 23.45
2021-12-31 $379k 10k 38.04
2021-09-30 $437k 9.5k 46.20